Axonics gets FDA nod for fourth-generation rechargeable neurostimulator
The new-generation neurostimulator, dubbed Axonics R20, requires to be recharged only once every six to 10 months for…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
01 Feb 23
The new-generation neurostimulator, dubbed Axonics R20, requires to be recharged only once every six to 10 months for…
27 Jan 23
Abbott’s Proclaim XR SCS system was previously approved in the US, in 2019, for the treatment of chronic…
27 Jan 23
International Markets Show Immediate and Increasing Demand for FDA-Cleared, CE Mark-Approved NeuroCap Device
20 Jan 23
Avail is a biopharmaceutical company focused on therapies for addiction, and substance abuse, and is also creating a…
19 Jan 23
VisAR is FDA cleared for stereotactic spine guidance and under review for cranial procedures
21 Dec 22
Truvaga is a handheld non-invasive vagus nerve stimulator that utilizes our proven technology to quickly and gently activate…
20 Dec 22
The Eterna SCS system leverages the company’s low-dose BurstDR stimulation that mimics natural firing patterns around the brain…
19 Dec 22
he single-use, implantable device acts as an endoluminal prothesis that is placed into a cerebral venous sinus stenosis…
16 Dec 22
The endovascular brain-computer interface (BCI) company will use the funding to support the development of its BCI product,…
13 Dec 22
The study, dubbed Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesions, is a single-arm clinical…